Back
Verisk Analytics Vs. Axsome Therapeutics Industry Stock Comparison
Sell
49
VRSK
Verisk Analytics
Last Price:
$291.92
Seasonality Move:
5%
Sell
23
AXSM
Axsome Therapeutics
Last Price:
$96.71
Seasonality Move:
29%
Sell
49
Verisk Analytics (VRSK)
is a Sell
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $285.78. The Score for VRSK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
VRSK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $95.65. The Score for AXSM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $285.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRSK is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $95.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.39 | Sell |
Relative Strength Index (14 RSI): | 46.03 | Sell |
Chaikin Money Flow: | 289961 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (284.18 - 297.26) | Sell |
Bollinger Bands (100): | (278.97 - 294.75) | Sell |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.16 | Sell |
Relative Strength Index (14 RSI): | 27.75 | Sell |
Chaikin Money Flow: | -108587 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106 - 126.46) | Sell |
Bollinger Bands (100): | (90.82 - 121.54) | Sell |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 289.83 | Sell |
20-day SMA: | 290.2 | Sell |
50-day SMA: | 291.76 | Sell |
200-day SMA: | 278.88 | Buy |
8-day EMA: | 287.71 | Sell |
20-day EMA: | 290 | Sell |
50-day EMA: | 289.55 | Sell |
200-day EMA: | 276.97 | Buy |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.69 | Sell |
20-day SMA: | 114.92 | Sell |
50-day SMA: | 118.82 | Sell |
200-day SMA: | 96.67 | Sell |
8-day EMA: | 102.96 | Sell |
20-day EMA: | 110.86 | Sell |
50-day EMA: | 113.08 | Sell |
200-day EMA: | 99.41 | Sell |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.34 per share, an increase this year of $1.79 per share, and an increase next year of $4.87 per share.
Verisk Analytics Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |